These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1711 related articles for article (PubMed ID: 29771163)

  • 1. Review of Saccharomyces boulardii as a treatment option in IBD.
    Sivananthan K; Petersen AM
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of probiotics in inflammatory bowel disease.
    Cain AM; Karpa KD
    Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review.
    Ganji-Arjenaki M; Rafieian-Kopaei M
    J Cell Physiol; 2018 Mar; 233(3):2091-2103. PubMed ID: 28294322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management.
    Kerman DH; Deshpande AR
    Postgrad Med; 2014 Jul; 126(4):7-19. PubMed ID: 25141239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taxonomic and phenotypic analysis of bifidobacteria isolated from IBD patients as potential probiotic strains.
    Bosselaar S; Dhelin L; Dautel E; Titecat M; Duthoy S; Stelmaszczyk M; Delory N; De Sousa Violante M; Machuron F; Ait-Abderrahim H; Desreumaux P; Foligné B; Monnet C
    BMC Microbiol; 2024 Jun; 24(1):233. PubMed ID: 38951788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
    Naseer M; Poola S; Ali S; Samiullah S; Tahan V
    Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical Considerations and the Intestinal Microbiome in Disease: Antibiotics for IBD Therapy.
    Fedorak RN; Ismond KP
    Dig Dis; 2016; 34(1-2):112-21. PubMed ID: 26982586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.
    Schultz M; Schölmerich J; Rath HC
    Dig Dis; 2003; 21(2):105-28. PubMed ID: 14571109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics and probiotics in treatment of inflammatory bowel disease.
    Gionchetti P; Rizzello F; Lammers KM; Morselli C; Sollazzi L; Davies S; Tambasco R; Calabrese C; Campieri M
    World J Gastroenterol; 2006 Jun; 12(21):3306-13. PubMed ID: 16733845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saccharomyces boulardii does not prevent relapse of Crohn's disease.
    Bourreille A; Cadiot G; Le Dreau G; Laharie D; Beaugerie L; Dupas JL; Marteau P; Rampal P; Moyse D; Saleh A; Le Guern ME; Galmiche JP;
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):982-7. PubMed ID: 23466709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
    Hedin C; Whelan K; Lindsay JO
    Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot trial of Saccharomyces boulardii in ulcerative colitis.
    Guslandi M; Giollo P; Testoni PA
    Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):697-8. PubMed ID: 12840682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: fungal alterations in inflammatory bowel diseases.
    Lam S; Zuo T; Ho M; Chan FKL; Chan PKS; Ng SC
    Aliment Pharmacol Ther; 2019 Dec; 50(11-12):1159-1171. PubMed ID: 31648369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics in the Treatment of Inflammatory Bowel Diseases.
    Guandalini S
    Adv Exp Med Biol; 2024; 1449():135-142. PubMed ID: 39060735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effects of Saccharomyces boulardii mediated by myeloid dendritic cells from patients with Crohn's disease and ulcerative colitis.
    Thomas S; Metzke D; Schmitz J; Dörffel Y; Baumgart DC
    Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G1083-92. PubMed ID: 21903765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut microbiota in inflammatory bowel disease.
    Macfarlane GT; Blackett KL; Nakayama T; Steed H; Macfarlane S
    Curr Pharm Des; 2009; 15(13):1528-36. PubMed ID: 19442170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics and prebiotics in Crohn's disease therapies.
    Lichtenstein L; Avni-Biron I; Ben-Bassat O
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):81-8. PubMed ID: 27048899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
    Pearce CB; Duncan HD; Timmis L; Green JR
    Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):439-43. PubMed ID: 10783998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics and Their Use in Inflammatory Bowel Disease.
    Amer M; Nadeem M; Nazir SUR; Fakhar M; Abid F; Ain QU; Asif E
    Altern Ther Health Med; 2018 May; 24(3):16-23. PubMed ID: 29135456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Probiotics in Crohn's Disease and in Pouchitis.
    Guslandi M
    J Clin Gastroenterol; 2015; 49 Suppl 1():S46-9. PubMed ID: 26447964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 86.